Farther Finance Advisors’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30 Buy
110
+9
+9% +$2 ﹤0.01% 6053
2026
Q2
$27 Hold
101
– – ﹤0.01% 5892
2026
Q1
$27 Buy
101
+1
+1% – ﹤0.01% 5626
2025
Q4
$28 Hold
100
– – ﹤0.01% 5379
2025
Q3
$42 Buy
+100
New +$38 ﹤0.01% 4877

Other funds holding IGC

Farther Finance Advisors's IGC Position: Q3 2026 in Review

Farther Finance Advisors increased its IGC Pharma (IGC) stake by 8.9% in Q3 2026, buying an estimated $2 and bringing the position to 110 shares worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #6053.

Farther Finance Advisors first reported a position in IGC in Q3 2025 and has held it in 5 quarters since. The position peaked at $42 in Q3 2025. 2 funds tracked by Wall St. Rank hold IGC as of Q3 2026.

  • Farther Finance Advisors held 110 shares of IGC Pharma worth $30 as of Q3 2026.
  • Farther Finance Advisors bought 9 IGC Pharma shares in Q3 2026, an estimated $2.
  • IGC Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6053 holding.
  • Farther Finance Advisors first reported a position in IGC Pharma in Q3 2025 and has held it in 5 quarters since.
  • Farther Finance Advisors's IGC Pharma position peaked at $42 in Q3 2025.
  • 2 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.